Infectious Diseases

Infectious Diseases


Drug Watch

FDA Approves Oritavancin for Skin Infections

Oritavancin (Orbactiv), administered as a single dose, is the third new antibiotic approved since May for treatment of skin and soft-tissue infections.

FDA Approves Tedizolid for Skin Infections

Tedizolid, an oxazolidinone, is the second new drug approved in the last month for treatment of skin and soft tissue infections.

HIV and ID Observations Blog

CDC Recommends Broader Use of Pre-Exposure Prophylaxis — Can We Make It Happen? Free

CDC is now recommending tenofovir/FTC (Truvada) for all Americans at high risk for HIV. Dr. Paul Sax offers his thoughts on the challenges ahead.

Guideline Watch

CDC Guidelines for Pre-Exposure Prophylaxis to Prevent HIV Infection

Daily oral tenofovir/FTC coupled with risk-reduction services and careful monitoring is recommended as one prevention option for high-risk men who have sex with men, heterosexuals, and injection-drug users.

Updated DHHS HIV Treatment Guidelines

This major revision includes a recommendation for less-frequent CD4-count monitoring, an updated list of recommended regimens, a discussion of “switching,“ and a new section on treatment costs.

Managing Drug Interactions in the Treatment of HIV-Associated TB

These updated guidelines provide recommendations for managing drug interactions between rifamycin antibiotics and four classes of antiretrovirals and for co-treatment of tuberculosis and HIV infection in children and pregnant women.

Prevention of Catheter-Associated Urinary Tract Infections

This document updates 2008 guidelines on prevention of catheter-associated urinary tract infections in acute care hospitals.